Effectiveness of the diabetic foot risk classification system of the international working group on the diabetic foot

Diabetes Care

Volumn 24, Issue 8, 2001, Pages 1442-1447

  Peters, Edgar J G ^a   Lavery, Lawrence A ^a,b,c  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

^b Diabetex Foot Care Center   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN;

ARTICLE; BLOOD; BLOOD PRESSURE; BODY MASS; CASE CONTROL STUDY; CLASSIFICATION; COMPARATIVE STUDY; DIABETIC ANGIOPATHY; DIABETIC FOOT; DIABETIC NEUROPATHY; FEMALE; FOLLOW UP; FOOT MALFORMATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; RISK ASSESSMENT; RISK FACTOR; TIME; UNITED STATES;

BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC FOOT; DIABETIC NEUROPATHIES; FEMALE; FOLLOW-UP STUDIES; FOOT DEFORMITIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; TEXAS; TIME FACTORS;

EID: 0035434053     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.8.1442     Document Type: Article

References (14)

1. Apelqvist J, Bakker K, Van Houtum WH, Nabuurs-Fransen MH, Schaper NC: International Consensus on the Diabetic Foot. In The International Working Group on the Diabetic Foot. Amsterdam, The Netherlands, John Wiley & Sons, 1999, p. 67
2. Armstrong DG, Harkless LB: Outcomes of preventative care in a diabetic foot specialty clinic. J Foot Ankle Surg 37:460-466, 1998
3. World Health Organization: WHO Expert Committee on Diabetes Mellitus. Second Report. Geneva, World Health Org., 1980 (641-680)
4. Mogensen CE: Renoproductive role of ACE inhibitors in diabetic nephropathy. Br Heart J 72 (Suppl. 3):S38-S45, 1994
5. Armstrong DG, Peters EJ, Athanasiou KA, Lavery LA: Is there a critical level of plantar foot pressure to identify patients at risk for neuropathic foot ulceration? J Foot Ankle Surg 37:303-307, 1998
6. McNeely MJ, Boyko EJ, Ahroni JE, Stensel VL, Reiber GE, Smith DG, Pecoraro RE: The independent contributions of diabetic neuropathy and vasculopathy in foot ulceration: how great are the risks? Diabetes Care 18:216-219, 1995
7. Beach KW, Strandness DE: Arteriosclerosis obliterans and associated risk factors in insulin-dependent and non-insulin-dependent diabetes. Diabetes 29:882-888, 1980
8. Young MJ, Breddy JL, Veves A, Boulton AJM: The prediction of diabetic neuro-pathic foot ulceration using vibration perception thresholds: a prospective study. Diabetes Care 17:557-560, 1994
9. Armstrong DG, Lavery LA, Vela SA, Quebedeaux TL, Fleischli JG: Choosing a practical screening instrument to identify patients at risk for diabetic foot ulceration. Arch Int Med 158:289-292, 1998
10. Lavery LA, Armstrong DG, Vela SA, Quebedeaux TL, Fleischli JG: Practical criteria for screening patients at high risk for diabetic foot ulceration. Arch Intern Med 158:158-162, 1998
11. Birke JA, Cornall MA, Jackson M: Relationship between hallux limitus and ulceration of the great toe. Sports Phys Ther J Orthop 10:172-176, 1988
12. Birke JA, Franks D, Foto JG: First ray joint limitation, pressure, and ulceration of the first metatarsal head in diabetes mellitus. Foot Ankle 16:277-284, 1995
13. Magruder-Habib K, Stevens HA, Alling WC: Relative performance of the MAST, VAST, and CAGE versus DM-III-R criteria for alcohol dependence. J Clin Epidemiol 46:435-441, 1993
14. Savage S, Estacio RO, Jeffers B, Schrier RW: Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care 19:1243-1248, 1996